21st North Inc logo

ULGX - 21st North Inc Share Price

$0.005 0.0  0.0%

Last Trade - 17/10/19

Sector
Healthcare
Size
Micro Cap
Market Cap £77.4k
Enterprise Value £3.81m
Revenue £9.40m
Position in Universe th / 6415
Bullish
Bearish
Unlock ULGX Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ULGX Revenue Unlock ULGX Revenue

Net Income

ULGX Net Income Unlock ULGX Revenue

Normalised EPS

ULGX Normalised EPS Unlock ULGX Revenue

PE Ratio Range

ULGX PE Ratio Range Unlock ULGX Revenue

Dividend Yield Range

ULGX Dividend Yield Range Unlock ULGX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ULGX EPS Forecasts Unlock ULGX Revenue
Profile Summary

21st North Inc., formerly Urologix Inc., was engaged in developing, manufacturing, marketing and distributing medical products. The Company offered its products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia (BPH). The Company has no operations. The Company intends to dissolve.

Directors
Last Annual June 30th, 2014
Last Interim March 31st, 2015
Incorporated May 29, 1991
Public Since May 30, 1996
No. of Shareholders: n/a
No. of Employees: 61
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange OTC Markets Group
Shares in Issue 21,817,726
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ULGX Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ULGX
Upcoming Events for ULGX
Similar to ULGX
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.